Exploring Three Undiscovered Gems In The Middle East Market
Uncategorized
Exploring Three Undiscovered Gems In The Middle East Market
08 mins
The Middle East market is currently navigating a complex landscape marked by geopolitical tensions and mixed performances across key indices, with Gulf stocks showing varied responses to ongoing regional conflicts. Despite these challenges, the region’s energy sector remains buoyed by elevated oil prices, offering potential support for broader market stability. In this dynamic environment, identifying promising stocks often involves looking beyond immediate volatility to find companies with strong fundamentals and growth potential that can thrive amid uncertainty.
Top 10 Undiscovered Gems With Strong Fundamentals In The Middle East
Name
Debt To Equity
Revenue Growth
Earnings Growth
Health Rating
Al Wathba National Insurance Company PJSC
10.35%
8.65%
-7.40%
★★★★★★
Ilex Medical
NA
-2.62%
-29.83%
★★★★★★
Terminal X Online
10.00%
13.43%
45.34%
★★★★★★
Saudi Azm for Communication and Information Technology
Let’s explore several standout options from the results in the screener.
Simply Wall St Value Rating: ★★★★★★
Overview: Dubai Refreshment (P.J.S.C.) is a food and beverage manufacturing and distribution company with operations in the United Arab Emirates and internationally, holding a market cap of AED1.98 billion.
Operations: The company generates revenue primarily from its soft drinks and related beverage products, totaling AED877.20 million. Its financial performance is characterized by a net profit margin of 8%.
Dubai Refreshment, a nimble player in the Middle East market, has shown impressive growth with earnings rising 17.8% over the past year, outpacing its industry. The company is debt-free now compared to five years ago when it had a debt to equity ratio of 1.2%, and boasts high-quality earnings. Recent financials reveal sales of AED 877 million and net income of AED 157 million for the last fiscal year, alongside an annual dividend increase to AED 1.10 per share. Despite its illiquid shares, Dubai Refreshment seems well-positioned with strong cash flow and no interest payment concerns due to zero debt obligations.
DFM:DRC Debt to Equity as at Apr 2026
Simply Wall St Value Rating: ★★★★★☆
Overview: Europower Enerji ve Otomasyon Teknolojileri Sanayi Ticaret Anonim Sirketi is engaged in the design, development, manufacturing, and sale of electrical system products in Turkey with a market capitalization of TRY32.39 billion.
Operations: Europower generates revenue primarily from its Energy and Electricity segment, amounting to TRY13 billion. The company’s financial performance is highlighted by a notable net profit margin trend.
Europower Enerji, a nimble player in the electrical industry, has shown impressive earnings growth of 105.6% over the past year, outpacing the industry’s 67.7%. The company reported sales of TRY 12.99 billion for 2025, up from TRY 10.76 billion the previous year, with net income climbing to TRY 600 million from TRY 292 million. Despite its high-quality non-cash earnings and a satisfactory net debt to equity ratio of 20.3%, Europower’s free cash flow remains negative at -TRY341 million as of December end. The company’s share price has been quite volatile recently but it continues to cover interest payments comfortably without concern for profitability runway issues.
IBSE:EUPWR Debt to Equity as at Apr 2026
Simply Wall St Value Rating: ★★★★★☆
Overview: Saudi Chemical Holding Company operates in the manufacturing, distribution, and retail sectors for a range of products including medicines, medical materials, pharmaceutical preparations, and medical equipment with a market capitalization of SAR7.34 billion.
Operations: Saudi Chemical Holding generates revenue primarily from its Medicines and Medical Supplies segment, which contributes SAR6.72 billion. The Explosives segment adds SAR395 million to the revenue stream, while the Production of Ammonium Nitrate accounts for SAR96.77 million.
Saudi Chemical Holding has shown resilience in a challenging market, with earnings growth of 15.1% over the past year, surpassing the Healthcare industry’s 14.2%. The company trades at a significant discount, about 30.3% below its estimated fair value, making it an attractive prospect for investors seeking undervalued opportunities. Despite a high net debt to equity ratio of 42.5%, interest payments are well covered by EBIT at 5.1 times coverage, indicating sound financial management amidst volatility in share price recently observed over three months. Recent results show improved sales of SAR 6.88 billion and net income rising to SAR 335 million from last year’s SAR 291 million, reflecting robust operational performance and strategic positioning within its sector.
SASE:2230 Debt to Equity as at Apr 2026
Seize The Opportunity
Interested In Other Possibilities?
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include DFM:DRC IBSE:EUPWR and SASE:2230.
